Fulgent Genetics, Inc. (FLGT) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 6 Buy, 3 Hold.
The consensus price target is $36.00, representing an upside of 122.6% from the current price $16.17.
Analysts estimate Earnings Per Share (EPS) of $0.33 and revenue of $0.28B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.41 vs est $0.33 (missed -533.3%). 2025: actual $-1.97 vs est $0.28 (missed -803.8%). Analyst accuracy: 0%.
FLGT Stock — 12-Month Price Forecast
$36.00
▲ +122.63% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Fulgent Genetics, Inc., the price target is $36.00.
The average price target represents a +122.63% change from the last price of $16.17.
FLGT Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Fulgent Genetics, Inc. in the past 3 months
EPS Estimates — FLGT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.41
vs Est $0.33
▼ 123.1% off
2025
Actual –$1.97
vs Est $0.28
▼ 114.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — FLGT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.283B
vs Est $0.282B
▲ 0.5% off
2025
Actual $0.323B
vs Est $0.325B
▼ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
